In brief

• The Ministry of Health is working on a mandatory register of payments made by pharmaceutical companies to doctors and other participants in the healthcare system.
• Data would be reported once a year and made publicly available.
• The solution is to be included in the drug policy for 2027–2032, which is announced for November.
• The Supreme Medical Chamber (Naczelna Izba Lekarska) and the pharmaceutical industry support the idea.

Register of cooperation with the pharmaceutical industry

The Ministry of Health is preparing a mandatory register that would contain information about payments made by pharmaceutical companies. It would cover not only doctors, but also foundations, patient organizations and healthcare providers (Firmy mają ujawniać, ile płacą lekarzom. Ministerstwo szykuje nowe regulacje – Business Insider Polska) (Rząd chce jawności wynagrodzeń. Chodzi o współpracę lekarzy z firmami farmaceutycznymi – Onet) (Rząd chce jawności. Firmy farmaceutyczne mają ujawniać, ile płacą lekarzom – Rzeczpospolita). According to findings of „Rzeczpospolita”, data on this cooperation would be reported once a year and made publicly available.

Connection with the new drug policy

The register is meant to be an element of the state's drug policy for 2027–2032, which the ministry intends to present in November. The idea thus appears as part of a broader plan concerning medicines and their financing, not as a separate regulation.

Support from medical circles and industry

According to reports, both organizations representing doctors, including the Supreme Medical Chamber (Naczelna Izba Lekarska), and the pharmaceutical industry support the creation of such a register. Neither the paying side nor the receiving side opposes the very idea of transparency.

What's next

At this stage it is not known in what form the register will be implemented or when it will start operating. The ministry plans to present details in November, together with the entire drug policy.